Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson’s disease

References

• Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. 2003. The role of actigraphy in the study of sleep and circadian rhythms. Sleep [ Internet]. 26:342–392. doi:10.1093/sleep/26.3.342.
   PubMed Web of Science ®Google Scholar
• Arora T, Taheri S. 2015. Associations among late chronotype, body mass index and dietary behaviors in young adolescents. Int J Obes (Lond) [ Internet]. 39:39–44. doi:10.1038/ijo.2014.157.
   PubMed Web of Science ®Google Scholar
• Artusi CA, Mishra M, Latimer P, Vizcarra JA, Lopiano L, Maetzler W, Merola A, Espay AJ. 2018. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. Park Relat Disord [ Internet]. 46:S53–S56. doi:10.1016/j.parkreldis.2017.07.022.
   PubMed Web of Science ®Google Scholar
• Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen J-P, Lefaucheur J-P, Césaro P, D’Ortho M-P, Drouot X. 2013. Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson’s disease. Nat Sci Sleep [ Internet]. 5:87–91. doi:10.2147/NSS.S41245.
   PubMedGoogle Scholar
• Burgess HJ, Eastman CI. 2008. Human tau in an ultradian light-dark cycle. J Biol Rhythms [ Internet]. 23:374–376. doi:10.1177/0748730408318592.
   PubMed Web of Science ®Google Scholar
• Cheart. 2008. Cosinor analysis MATLAB program [ Internet]. https://www.mathworks.com/matlabcentral/fileexchange/20329-cosinor-analysis. [last accessed July 2018].
   Google Scholar
• Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, Ronda JM, Silva EJ, Allan JS, Emens JS, et al. 1999. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science [ Internet]. 284:2177–2181. doi:10.1126/science.284.5423.2177.
   PubMed Web of Science ®Google Scholar
• Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, et al. 2017. Biomarker-driven phenotyping in Parkinson’s disease: A translational missing link in disease-modifying clinical trials. Mov Disord [ Internet]. 32:319–324. doi:10.1002/mds.26913.
   PubMed Web of Science ®Google Scholar
• Fahn S. 2008. The history of dopamine and levodopa in the treatment of Parkinson’s disease. Mov Disord [ Internet]. 23(Suppl 3):S497–508. doi:10.1002/mds.22028.
   PubMedGoogle Scholar
• Fifel K, Videnovic A. 2019. Chronotherapies for Parkinson’s disease. Prog Neurobiol [ Internet]. 174:16–27. doi:10.1016/j.pneurobio.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Gros P, Videnovic A. 2017. Sleep and circadian rhythm disorders in Parkinson’s disease. Curr Sleep Med Rep. 3:222–234.
   PubMedGoogle Scholar
• Hood S, Cassidy P, Cossette M-P, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S. 2010. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci [ Internet]. 30:14046–14058. doi:10.1523/JNEUROSCI.2128-10.2010.
   PubMed Web of Science ®Google Scholar
• Hopkins S, Morgan PL, Schlangen LJM, Williams P, Skene DJ, Middleton B. 2017. Blue-enriched lighting for older people living in care homes: effect on activity, actigraphic sleep, mood and alertness. Curr Alzheimer Res [ Internet]. 14:1053–1062. doi:10.2174/1567205014666170608091119.
   PubMed Web of Science ®Google Scholar
• Horak FB, Mancini M. 2013. Objective biomarkers of balance and gait for Parkinson’s disease using body-worn sensors. Mov Disord [ Internet]. 28:1544–1551. doi:10.1002/mds.v28.11.
   PubMed Web of Science ®Google Scholar
• Hornykiewicz O. 1966. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev [ Internet]. 18:925–964. http://www.ncbi.nlm.nih.gov/pubmed/5328389.
   PubMed Web of Science ®Google Scholar
• Hulsegge G, Loef B, van Kerkhof LW, Roenneberg T, van der Beek AJ, Proper KI. 2018. Shift work, sleep disturbances and social jetlag in healthcare workers. J Sleep Res. 28:e12802.
   PubMed Web of Science ®Google Scholar
• Johansson D, Malmgren K, Alt Murphy M. 2018. Wearable sensors for clinical applications in epilepsy, Parkinson’s disease, and stroke: a mixed-methods systematic review. J Neurol [ Internet]. 265:1740–1752. doi:10.1007/s00415-018-8786-y.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Lang AE. 2015. Parkinson’s disease. Lancet (Lond, Eng) [ Internet]. 386:896–912. doi:10.1016/S0140-6736(14)61393-3.
   PubMed Web of Science ®Google Scholar
• Korshunov KS, Blakemore LJ, Trombley PQ. 2017. Dopamine: a modulator of circadian rhythms in the central nervous system. Front Cell Neurosci. 11:1–17.
   PubMed Web of Science ®Google Scholar
• Madrid-Navarro CJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Campos M, Ruiz-Abellán F, Madrid JA, Rol MA. 2018. Multidimensional circadian monitoring by wearable biosensors in Parkinson’s disease. Front Neurol [ Internet]. 9:157. doi:10.3389/fneur.2018.00157.
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Quante M, Godbole S, James P, Hipp JA, Marinac CR, Mariani S, Cespedes Feliciano EM, Glanz K, Laden F, et al. 2017. Variation in actigraphy-estimated rest-activity patterns by demographic factors. Chronobiol Int [ Internet]. 34:1042–1056. doi:10.1080/07420528.2017.1337032.
   PubMed Web of Science ®Google Scholar
• Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju Y-ES. 2018. Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol [ Internet]. 75:582–590. doi:10.1001/jamaneurol.2017.4719.
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong YL, Lee JK, Halberg F. 1979. Methods for cosinor-rhythmometry. Chronobiologia [ Internet]. 6:305–323. Available from: http://www.ncbi.nlm.nih.gov/pubmed/548245.
   PubMedGoogle Scholar
• Niwa F, Kuriyama N, Nakagawa M, Imanishi J. 2011. Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson’s disease. Auton Neurosci [ Internet]. 165:195–200. doi:10.1016/j.autneu.2011.07.010.
   PubMed Web of Science ®Google Scholar
• Poceta JS, Parsons L, Engelland S, Kripke DF. 2009. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson’s disease. Sleep Med [ Internet]. 10:129–133. doi:10.1016/j.sleep.2007.11.002.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mitoma H, Yoneyama M. 2017. Quantitative analysis of motor status in Parkinson’s disease using wearable devices: from methodological considerations to problems in clinical applications. Parkinsons Dis. 2017:1–9.
   Web of Science ®Google Scholar
• Takekawa H, Suzuki K, Hirata K, Miyamoto T, Kaji Y, Miyamoto M. 2008. Circadian variation of core body temperature in Parkinson disease patients with depression: a potential biological marker for depression in Parkinson disease. Neuropsychobiology. 56:172–179.
   Web of Science ®Google Scholar
• Thannickal TC, Lai -Y-Y, Siegel JM. 2007. Hypocretin (orexin) cell loss in Parkinson’s disease. Brain [ Internet]. 130:1586–1595. doi:10.1093/brain/awm097.
   PubMed Web of Science ®Google Scholar
• Van Someren EJW, Hagebeuk EEO, Lijzenga C, Scheltens P, De Rooij SEJA, Jonker C, Pot AM, Mirmiran M, Swaab DF. 1996. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry. 40:259–270.
   PubMed Web of Science ®Google Scholar
• Vetter C. 2018. Circadian disruption: what do we actually mean? Eur J Neurosci. 1–20.
   Web of Science ®Google Scholar
• Videnovic A, Golombek D. 2013. Circadian and sleep disorders in Parkinson’s disease. Exp Neurol [ Internet]. 243:45–56. doi:10.1016/j.expneurol.2012.08.018.
   PubMed Web of Science ®Google Scholar
• Videnovic A, Golombek D. 2017. Circadian dysregulation in Parkinson’s disease. Neurobiol Sleep Circadian Rhythm [ Internet]. 2:53–58. doi:10.1016/j.nbscr.2016.11.001.
   PubMedGoogle Scholar
• Waldvogel D, Sürücü O, Baumann CR, Werth E, Baumann-Vogel H, Imbach LL, Stieglitz L. 2017. The impact of subthalamic deep brain stimulation on sleep–wake behavior: a prospective electrophysiological study in 50 Parkinson patients. Sleep. 40.
   Web of Science ®Google Scholar
• Whitehead DL, Davies ADM, Playfer JR, Turnbull CJ. 2008. Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov Disord. 23:1137–1145.
   PubMed Web of Science ®Google Scholar
• Wienecke M, Werth E, Poryazova R, Baumann-Vogel H, Bassetti CL, Weller M, Waldvogel D, Storch A, Baumann CR. 2012. Progressive dopamine and hypocretin deficiencies in Parkinson’s disease: is there an impact on sleep and wakefulness? J Sleep Res [ Internet]. 21:710–717. doi:10.1111/jsr.2012.21.issue-6.
   PubMed Web of Science ®Google Scholar
• Witkovsky P. 2004. Dopamine and retinal function. Doc Ophthalmol [ Internet]. 108:17–40. doi:10.1023/B:DOOP.0000019487.88486.0a.
   PubMed Web of Science ®Google Scholar
• Zampieri C, Salarian A, Carlson-Kuhta P, Aminian K, Nutt JG, Horak FB. 2010. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson’s disease. J Neurol Neurosurg Psychiatry [ Internet]. 81:171–176. doi:10.1136/jnnp.2009.173740.
   PubMed Web of Science ®Google Scholar